BCM
WINT

Brookstone Capital Management’s Windtree Therapeutics Inc WINT Stock Holding History

Brookstone Capital Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,429
Closed -$4K – 251
2015
Q4 		$4K Buy
+1,429
New +$5.86K ﹤0.01% 157

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Brookstone Capital Management's WINT Position: Q1 2016 in Review

Brookstone Capital Management sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 1,429 shares — an estimated $4K sold.

Brookstone Capital Management first reported a position in WINT in Q4 2015 and held it in 1 quarter. The position peaked at $4K in Q4 2015. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

  • Brookstone Capital Management reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
  • Brookstone Capital Management sold 1,429 Windtree Therapeutics Inc shares in Q1 2016, an estimated $4K.
  • Brookstone Capital Management first reported a position in Windtree Therapeutics Inc in Q4 2015 and held it in 1 quarter.
  • Brookstone Capital Management's Windtree Therapeutics Inc position peaked at $4K in Q4 2015.
  • 34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on Brookstone Capital Management's 13F filing for Q1 2016, filed 14 Apr 2016.